Advertisement

Pharmacy World and Science

, Volume 27, Issue 2, pp 104–107 | Cite as

Utilisation of macrolides and the development of Streptococcus pyogenes resistance to erythromycin

  • Karel UrbánekEmail author
  • Milan Kolář
  • Luboslava Čekanová
Article

Abstract

Objectives: The aim of the study was to evaluate the relationship between the development of the resistance of Streptococcus pyogenes strains to erythromycin and the utilisation of macrolides in the Olomouc region, Czech Republic.

Method: During the period 1997–2001, data for utilisation of macrolides was obtained from the database of regional General Health Insurance Company and expressed in defined daily doses per 1000 patients per day. S. pyogenes strains were isolated from community patients suffering from acute bacterial tonsillitis. Their susceptibility to antibiotics was assessed by the disk diffusion method.

Result: Utilisation of macrolides increased by 13% in the period 1997–2001; their utilisation represented 11.40% of total antibiotic prescription in 1997 and 15.48% in 2001. Occurrence of erythromycin-resistant S. pyogenes strains increased significantly from 14% in 1997 to 32% in the year 2001 (P < 0.01). In 2000, macrolides consumption decreased non-significantly, but with no concomitant decrease in erythromycin-resistant S. pyogenes strains occurrence. Absolute susceptibility of S. pyogenes, the most important bacterial pathogen in community-acquired bacterial tonsillitis, to penicillin contrasts with increasing macrolide resistance.

Conclusions: The study documents the influence of increased utilisation of macrolides on bacterial resistance. Penicillin should be a first choice antibiotic in acute bacterial tonsillitis; macrolides should only be reserved for patients allergic to penicillins.

Keywords

ATC-DDD system Antibiotics Czech Republic Drug resistance Drug use Macrolides Streptococcus pyogenes 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    York, MK, Gibbs, L, Perdreau-Remington, F., Brooks, GF 1999Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco bay area of northern CaliforniaJ Clin Microbiol.37172731PubMedGoogle Scholar
  2. 2.
    Gerber, MA. 1995Antibiotic resistance in group A streptococciPediatr Clin N Am199553951Google Scholar
  3. 3.
    Hyder, SL, Streitfeld, MM. 1973Inducible and constitutive resistance to macrolide antibiotics and lincomycin in clinically isolated strains of Streptococcus pyogenes Antimicrob AgentsChemother.432731Google Scholar
  4. 4.
    Kataja, J, Huovinen, P, Skurnik, M, Seppäla, H. 1999Erythromycin resistance genes in Group A Streptococci in FinlandAntimicrob Agents Chemother434852PubMedGoogle Scholar
  5. 5.
    Seppäla, H, Nissinen, A, Yu, P., Huovinen, Q 1993Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in FinlandJ Antimicrob Chemother.3288591PubMedGoogle Scholar
  6. 6.
    6 Sutcliffe, J, Tait-Kamradt, A, Wondrack, L. 1996Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux systemAntimicrob Agents Chemother.40181724PubMedGoogle Scholar
  7. 7.
    Seppäla, H, Klaukka, T, Lehtonen, R, Nenonen, E, Huovinen, P. 1995Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococciClin Infect Dis.21137885PubMedGoogle Scholar
  8. 8.
    Seppäla, H, Klaukka, T, Vuopio-Varkila, J, Muotiala, A, Helenius, H, Lager, K, Huovinen, P. 1997The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in FinlandN Engl J Med.3374416CrossRefPubMedGoogle Scholar
  9. 9.
    Giovanetti, E, Montanan, MP, Mingoia, M, Varaldo, PE. 1999Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogenicity of inducibly resistant strainsAntimicrob Agents Chemother.43193540PubMedGoogle Scholar
  10. 10.
    Pérez-Trallero, E, Fernández-Mazarrasa, C, García-Rey, C, Bouza, E, Aguilar, L, Garcia-de-Lomas, J.,  et al. 2001Antimicrobial suceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: result of a 1-year (1998-1999) multicenter surveillance study in SpainAntimicrob Agents Chemother.45333440CrossRefPubMedGoogle Scholar
  11. 11.
    Seppäla, H, Nissinen, A, Jarvinen, H, Huovinen, S, Henriksson, T, Herva, E.,  et al. 1992Resistance to erythromycin in group A streptococciN Engl J Med.3262927PubMedGoogle Scholar
  12. 12.
    Hölmström, L, Nyman, B, Rosengren, M, Wallander, S, Ripa, T. 1990Outbreaks of infections with erythromycin-resistant group A strep-tococci in child day care centresScand J Infect Dis.2217985PubMedGoogle Scholar
  13. 13.
    Cornaglia, G, Ligozzi, M, Mazzariol, A, Valentini, M, Orefici, G., Fontana, R 1996Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy 1993–1995Emerging Dis.233942Google Scholar
  14. 14.
    Phillips, G, Parratt, D, Orange, GV, Harpar, I, McEwan, H, Young, N. 1990Erythromycin-resistant Streptococcus pyogenesJ Antimicrob Chemother.2572324PubMedGoogle Scholar
  15. 15.
    Pérez-Trallero, E, Urbieta, M, Montes, M, Ayestaran, I, Marimon, JM. 1998Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, SpainEur J Clin Microbiol Infect Dis.172531CrossRefPubMedGoogle Scholar
  16. 16.
    Anatomical therapeutic chemical (ATC) index (including defined daily doses (DDDs) for plain substances). WHO collaboration centre for drugs statistics methodology, Oslo, 2001Google Scholar
  17. 17.
    National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Sixth informational supplement. Nat Comm Clin Lab Standards, Villanova, PA, 1995Google Scholar
  18. 18.
    Granizo, JJ, Aguilar, L, Casal, J, Dal-Ré, R, Baquero, F. 2000Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997)J Antimicrob Chemother.4695964CrossRefPubMedGoogle Scholar
  19. 19.
    Cars, O. 2001Variation in antibiotic use in the European UnionLancet.35718513CrossRefPubMedGoogle Scholar
  20. 20.
    Urbášková P and Working Group Surveillance of the antibiotic resistance of the most common bacterial pathogens causing respiratory tract infections in the Czech Republic. Remedia 2000; 10: 195-203Google Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Karel Urbánek
    • 1
    Email author
  • Milan Kolář
    • 3
  • Luboslava Čekanová
    • 2
  1. 1.Department of Pharmacology, Faculty of MedicinePalacký UniversityOlomoucCzech Republic
  2. 2.OlomoucCzech Republic
  3. 3.Department of Microbiology, Faculty of MedicinePalacký UniversityOlomoucCzech Republic

Personalised recommendations